Veness Adam M (CIK 1778623) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy DNTH (15,000 shares), Buy DNTH (3,833 shares), Sell DNTH (3,217 shares), Sell DNTH (616 shares), Buy DNTH (16,167 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Buy | 15,000 | $272,550 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Buy | 3,833 | $68,534 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Sell | 3,217 | $355,832 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Sell | 616 | $68,487 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Buy | 16,167 | $289,066 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Sell | 16,167 | $1.8M |
| 2026-06-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Buy | 30,000 | $536,400 |
| 2026-06-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Sell | 16,771 | $1.3M |
| 2026-06-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | SVP, General Counsel and Sec. | Sell | 13,229 | $1.1M |
Source: SEC Form 4 filings · as of 2026-08-14